DarioHealth Corp. logo

DarioHealth Corp.

DRIO | NASDAQ
Chart Builder DCF Calculator
$7.07
-$0.13 (-1.81%)
At close: Sep 21, 2026, 4:00 PM ET
$6.95
-$0.12 (-1.70%)
After-hours: Sep 21, 2026, 4:27 PM ET

Market Data

Market Cap
$52.64M
Enterprise Value
$69.85M
Beta
1.12
Average Volume
17.73K
Shares Outstanding (Diluted)
9.34M
Shares Change YoY
-81.17%
Institutional Ownership
9.02%
Exchange
NASDAQ
ISIN
US23725P3082

Price Performance

Price Change 1M
-5.5%
Price Change 3M
18.0%
Price Change 6M
-8.2%
Price Change YTD
-32.8%
Price Change 1Y
-9.1%
Price Change 3Y
-88.9%
Price Change 5Y
-97.5%
1M CAGR (ann.)
-7.1%
1Y CAGR (ann.)
9.4%
5Y CAGR (ann.)
-51.2%
All-Time CAGR
-39.6%

Valuation

PE Ratio
10.25
Forward PE
N/A
PEG Ratio
0.11
Forward PEG
-0.28
PS Ratio
2.46
Forward PS
1.80
PB Ratio
0.94
P/FCF Ratio
-2.08
P/Adj. FCF Ratio
-1.78
P/OCF Ratio
-2.67
EV/Sales
3.33
EV/EBIT
-2.21
EV/EBITDA
-2.35
EV/FCF
-2.81
Earnings Yield
9.8%
FCF Yield
-48.1%
Adj. FCF Yield
-56.1%

Financial Health

Net Debt
$17.38M
Total Debt
$32.41M
Cash & Short-Term Investments
$14.25M
Total Assets
$96.59M
Current Ratio
2.31
Quick Ratio
1.92
Debt / Equity Ratio
0.59
Debt / EBITDA
-1.09
Debt / FCF
-1.30
OCF / Debt
-0.76
Interest Coverage
-12.35
Altman Z-Score
-6.73
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
56.1%
Operating Profit Margin
-328.8%
EBITDA Margin
-141.7%
Net Profit Margin
322.8%
FCF Margin
-118.5%
Adj. FCF Margin
-138.1%
SBC / Revenue
19.6%
SBC Impact (per share)
-16.5%

Returns

Return on Assets
70.2%
Return on Equity
104.2%
Return on Invested Capital
-78.4%
Return on Capital Employed
-79.4%
Return on Tangible Assets
280.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
-7.6%
Revenue CAGR 5Y
10.1%
Revenue CAGR 10Y
27.7%
EPS CAGR 3Y
185.1%
EPS CAGR 5Y
69.4%
EPS CAGR 10Y
38.9%
FCF CAGR 3Y
25.9%
FCF CAGR 5Y
19.4%
FCF CAGR 10Y
-10.2%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
-110.1%
Revenue Growth Next 3Y
26.0%
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.51
EPS Growth Est (next Q)
-72.4%
Revenue Est (next Q)
$5.24M
Revenue Growth Est (next Q)
4.7%

Fair Value Estimates

Graham Number
$9.57
Graham Upside
35.4%
Lynch Fair Value
$17.25
Lynch Upside
144.0%
Price Target
$12.50
Price Target Upside
76.8%

Cash Flow

Operating Cash Flow
$-24.76M
Free Cash Flow
$-24.89M
Adj. Free Cash Flow
$-29M
FCF Per Share
-$2.66
OCF Per Share
-$2.65
OCF/S Ratio
-117.9%

Income Statement

Revenue
$21M
Gross Profit
$11.78M
Operating Income
$-69.05M
EBITDA
$-29.75M
Net Income
$67.78M
EPS (Diluted)
$0.69
Revenue / Employee
$128.83K
Profit / Employee
$415.82K
Employees
163

© 2026 bestshares.com. All rights reserved.